ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Hot Features

Registration Strip Icon for charts Regístrate para obtener gráficos en tiempo real, herramientas de análisis y precios.

NXTC NextCure Inc

1.48
-0.01 (-0.67%)
03 May 2024 - Cerrado
Retrasado por 15 minutos
Nombre de la Acción Símbolo de la Acción Bolsa de Valores Tipo de Valor
NextCure Inc NXTC NASDAQ Acción Común
  Variación del Día (ptos.) Variación del Día (%) Último Precio Hora
-0.01 -0.67% 1.48 23:00:08
Precio de Apertura Precio Mínimo Precio Máximo Precio de cierre Precio Anterior
1.60 1.49 1.60 1.53 1.49
más cotizaciones de acciones »

Noticias Recientes

Fecha Hora Fuente Noticia
02/5/202415:05GLOBENextCure Provides Business Update and Reports First Quarter..
24/4/202415:05GLOBENextCure to Present Phase 1b Data of NC410 in Combination..
08/4/202406:00GLOBENextCure and LCB Present Preclinical Data on B7-H4 Antibody..
04/4/202406:05GLOBENextCure Appoints Dr. Rakesh Dixit to Scientific Advisory..
02/4/202406:00GLOBENextCure to Present at 23rd Annual Needham Virtual..
21/3/202407:55GLOBENextCure Provides Business Update and Reports Full Year 2023..
05/3/202407:05GLOBENextCure Publishes Preclinical Data Demonstrating Function..
01/2/202415:45EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/2/202415:45EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/2/202415:44EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/2/202415:44EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/2/202415:43EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/2/202415:43EDGAR2Form 4 - Statement of changes in beneficial ownership of..
18/1/202415:05GLOBENextCure Presents Preclinical Data on a Novel Therapeutic..
21/12/202306:05GLOBENextCure Publishes Non-Clinical Data Demonstrating..
14/12/202306:15EDGAR2Form 8-K - Current report
14/12/202305:45GLOBENextCure Provides Year-End Clinical Pipeline Updates
20/11/202306:00GLOBENextCure to Present at the 35th Annual Piper Sandler..
15/11/202315:05GLOBENextCure Publishes Non-Clinical Data Defining the Mechanism..
02/11/202315:20EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
02/11/202315:10EDGAR2Form 8-K - Current report
02/11/202315:05GLOBENextCure Provides Business Update and Reports Third Quarter..
17/10/202307:05GLOBEPreclinical Data Demonstrate Anti-Siglec-15 Treatment..
26/9/202315:05GLOBENextCure Presents Preclinical Data on NC181, a Novel..
12/9/202307:05GLOBEA Phase 2 Study of Anti-Siglec-15 Antibody, NC318, in..
07/9/202315:05GLOBENextCure and Nordic Bioscience Publish Review Article on the..
05/9/202315:05GLOBEPreclinical Data Demonstrate Potential Application of..
31/8/202306:00GLOBENextCure to Present at the H.C. Wainwright 25th Annual..
04/8/202315:58EDGAR2Form S-8 - Securities to be offered to employees in employee..
04/8/202315:30EDGAR2Form S-3 - Registration statement under Securities Act of..
03/8/202315:26EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
03/8/202315:16EDGAR2Form 8-K - Current report
03/8/202315:05GLOBENextCure Provides Business Update and Reports Second Quarter..
19/7/202315:05EDGAR2Form 8-K - Current report
21/6/202315:05GLOBENextCure Presents Non-Clinical Data Defining the Mechanism..
09/5/202306:00GLOBENextCure to Present at the JMP Securities Life Sciences..

Su Consulta Reciente

Delayed Upgrade Clock